Reaction of α-halo- and α,α-dihalo-β-oxoaldehydes witho- andm-phenylenediamines
摘要:
alpha-Halo-beta-oxoaldehydes react with o- and m-phenylenediamines to give alpha-halo-beta-oxoenamines. In the case of o-phenylenediamine, the initially formed monoenamine undergoes concurrent intramolecular cyclization to give benzimidazole and a halocarbonyl compound. alpha,alpha-Dihalo-beta-oxoaldehydes react with o- and m-phenylenediamines according to the haloformic decomposition scheme involving formylation of amino groups.
SELF-REGENERATING ANTIOXIDANT CATALYSTS AND METHODS OF USING THE SAME
申请人:Clemson University
公开号:US20160151773A1
公开(公告)日:2016-06-02
The present invention relates to self-regenerating antioxidant catalysts and methods of using the same.
本发明涉及自再生抗氧化剂催化剂及其使用方法。
Methods of Forming Carbene-Functionalized Composite Materials
申请人:Queen's University at Kingston
公开号:US20190169132A1
公开(公告)日:2019-06-06
Deposition of carbene monolayers that excluded starting anions, such as iodide ions, has been achieved. Anions such as iodide are a typical contaminant in carbene hydrogen carbonate salts when synthesized using the state-of-the-art method. A method is described for eliminating substantially all starting anion (e.g., iodide) contamination from the monolayer. Air stable, purified carbenes precursors were used to deposit an intact monolayer on the surface of some industrially relevant metals. The monolayer's ability to protect these metals against, for example, oxidation has been demonstrated.
Compounds of the general formula (I), their tautomeric forms, their stereoisomers, their analogs, their prodrugs, their isotopes, their N-oxides, their metabolites, their pharmaceutically acceptable salts, polymorphs, solvates, optical isomers, clathrates, co-crystals, combinations with suitable medicament, pharmaceutical compositions containing them, methods of making of the above compounds, and their use as antiviral candidate, more specifically as anti-HCV are disclosed.
BENZIMIDAZOLES AND ANALOGS AS RHO KINASE INHIBITORS
申请人:Feng Yangbo
公开号:US20110052562A1
公开(公告)日:2011-03-03
Compounds useful as Rho kinase inhibitors according to formula IA or IB: wherein A, B, D, E, R
1
, R
2
and Ar
1
are as defined herein, and any tautomer, salt, stereoisomer, hydrate, solvent, or prodrug thereof, pharmaceutical compositions, methods of treatment, and synthetic methods are provided.
benzimidazole) perovskite single crystals by intermediate-phase engineering (IPE). 1D (DMF)2BMPbBr3 intermediate-phase single crystals were structurally decoupled and transformed to perfect 2D BM2PbBr4 seed crystals with a certain thickness, presenting a huge advantage over the extrathin crystal sheets in random stacking by natural crystallization. Furthermore, the new BM with conjugated structures we obtained
二维 Ruddlesden–Popper (RP) 钙钛矿已展示出高性能发射体,大尺寸钙钛矿单晶一直是高效光电器件的追求。然而,由于层间相互作用弱、各向异性强,大尺寸、高质量的二维RP钙钛矿单晶仍然难以获得。在这里,我们展示了一种通过中间相工程 (IPE) 合成厘米级 2D BM 2 PbBr 4(BM = 苯并咪唑)钙钛矿单晶的合理设计策略。一维 (DMF) 2 BMPbBr 3中间相单晶在结构上解耦并转化为完美的二维 BM 2 PbBr 4具有一定厚度的晶种,在自然结晶的随机堆叠方面比超薄晶体片具有巨大的优势。此外,我们作为 2D RP 钙钛矿的 A 位点获得的具有共轭结构的新 BM 增强了激子限制,导致激子结合能达到惊人的 368.2 meV。发射衰减时间缩短至0.98 ns,是所有钙钛矿材料中最小的。为 2D RP BM 2 PbBr 4 – x Cl x ( x= 1、2、3 和